Strategies for Maintenance, Re-validation, and Continued Monitoring

The presentation will cover cleaning post-shutdown, maintenance, risk-based routine monitoring, trending cleaning data, and utilizing dated validation packages for efficient cleaning.
  • Tuesday
  • October
  • 15
  • 2024
10:00 AM PDT | 01:00 PM EDT
Duration: 60 Minutes
IMG Fred Ohsiek
Webinar Id: 60380
Live
Session
$119.00
Single Attendee
$249.00
Group Attendees
Recorded
Session
$159.00
Single Attendee
$359.00
Group Attendees
Combo
Live+Recorded
$249.00
Single Attendee
$549.00
Group Attendees

Overview

In the presentation, we will discuss cleaning requirements after a shutdown and maintenance work. We will also explore how to create a risk-based efficient routine monitoring program, trending cleaning data, and how to leverage dated validation packages.

Why you should Attend

Regulatory expectation is that companies have a program for maintaining the validation state. Firms often don't have a program or don't have an efficient testing process.

Firms are also challenged on how to manage dated validation packages or how to determine the type of testing or testing frequency. Dated cleaning validation packages and weak or non-existent continued process verification (CPV) program can be a high regulatory inspection risk.

Areas Covered in the Session

  • Managing shut-downs efficiently and cleaning after maintenance
  • Examine when re-validation is appropriate 
  • Learn how to create an efficient but robust science risk-based continued monitoring program 
  • Routine monitoring case study

Who Will Benefit

  • Heads of Sites
  • Validation
  • Quality Assurance
  • Operation Managers,
  • Validation Engineers Responsible for Cleaning Validation

Speaker Profile

Fred Ohsiek Fred Ohsiek earned his BS in Chemistry from University of South Florida. He has 24 plus years of validation FTE and consultant experience, with emphasis in cleaning validation. Prior to transitioning to pharma his experience includes 7 years of R&D while at the USDA.

He has been fortunate to work for 7 major pharmaceuticals (Catalent, AstraZeneca, Boehringer Ingelheim, Teva, Astellas, Bayer, and Novo Nordisk) where he was considered the cleaning validation SME in most of his roles.

Working with various routes of administration (OSD, parenteral, softgels) in green and brown field small and large molecule manufacturing projects has provided Fred a very broad cache of experience.

Fred also obtained “cleaning chemistry” experience while working as a Sr Global Technical Manager at Ecolab (Life Science division).

Currently, he supports industry by creating tailored justifications, reducing the validation footprint via risk assessments, creating startup CV programs, remediating legacy processes, and increasing manufacturing capability as a cleaning process/cleaning validation consultant. He enjoys solving complicated validaton issues.

He was one of the authors of the ISPE Cleaning Validation Lifecycle - Application, Methods, and Controls guidance, and he regularly presents at conferences, nationally and globally.